Cargando…
The UCA1 and microRNA-18a signaling pathway mediates the irisin-lowering effect of metformin in the management of polycystic ovary syndrome
INTRODUCTION: The present study aimed to clarify the underlying mechanism of metformin (met) in the management of polycystic ovary syndrome (PCOS) and to explore the role of the UCA1/microRNA-18a signaling pathway in the control of PCOS. MATERIAL AND METHODS: Real-time PCR was performed to compare t...
Autores principales: | Wang, Wei, Hua, Tian, Li, Xiaodong, Zhang, Xinxian, Hao, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Termedia Publishing House
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8924822/ https://www.ncbi.nlm.nih.gov/pubmed/35316895 http://dx.doi.org/10.5114/aoms/103379 |
Ejemplares similares
-
Impaired Prolactin-Lowering Effects of Metformin in Women with Polycystic Ovary Syndrome
por: Krysiak, Robert, et al.
Publicado: (2023) -
The serum level of irisin, but not asprosin, is abnormal in polycystic ovary syndrome patients
por: Chang, Chia Lin, et al.
Publicado: (2019) -
MicroRNAs Related to Polycystic Ovary Syndrome (PCOS)
por: Sørensen, Anja Elaine, et al.
Publicado: (2014) -
Association of the Pro12Ala Polymorphism with the Metabolic Parameters in Women with Polycystic Ovary Syndrome
por: Zaki, Moushira, et al.
Publicado: (2017) -
Identification of Differentially Expressed MicroRNAs in the Ovary of Polycystic Ovary Syndrome with Hyperandrogenism and Insulin Resistance
por: Lin, Lin, et al.
Publicado: (2015)